Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Compostie Portfolio Midday Report (3/19/13)

|Includes: AAPL, ANH, DHCP, EBIX, FL, KLAC, NAT, NYMT, Walgreens Boots Alliance, Inc. (WBA), XIN

Dow Jones Industrial Average -0.34%
NASDAQ Composite -0.60%
S&P 500 -0.41%
Russell 2000 -0.53%
Pretty Girls and Railroads +0.26%
Widows and Orphans +0.22%
Climbers and Dogs +0.08%
Cumulative +0.19%
  • Cyprus levy concerns weigh on US stocks
    Mar 19 2013 15:13 GMT
    Early gains on Wall Street fizzled out, as fears over imposing a levy on bank deposits in Cyprus overshadowed positive US housing data showing home construction rose in February. The benchmark S&P 500 index was trading marginally lower at 1,550.55, pulling away from near-record levels of last week. The Dow...
  • Cairn adds Senegal to exploration list
    Mar 19 2013 08:35 GMT
    Cairn Energy has added the west African country of Senegal to its list of prospective exploration targets as it seeks to reinvent itself following the sale of its main asset in India. The Edinburgh-based oil company, that was a FTSE 100 constituent until the return of $3.5bn to shareholders at...
  • No rush for entry as India opens retail doors
    Mar 19 2013 06:39 GMT
    In most economies, retailers are retailers. Some, like supermarkets, department stores and pharmacies, sell products from many different brands, while others, like Ikea and many clothiers, sell items all tagged with an in-house label. Policy-wise, though, they are usually treated pretty much alike. India, however, is not most economies. In...
  • Wellcome pushes for release of drug results
    Mar 19 2013 00:03 GMT
    The Wellcome Trust, one of the world's largest medical funders, is urging researchers to release more details of their drug tests. The UK-based charity says it now "encourages" its grant recipients to release trial data while cautioning on the need to respect patient confidentiality. "Researchers are encouraged to explore opportunities...
  • Defensive AstraZeneca punts on Cambridge
    Mar 19 2013 00:01 GMT
    Karma is revenging itself on George Osborne. In last year's budget he trumpeted news that GlaxoSmithKline would spend £500m on a Cumbrian R&D hub as a vindication of the government's innovation policy. But his 2013 address on the state of the economy will come just after AstraZeneca announced it is...


Portfolio Movers


Gainers Today's Market Change
Walgreen Co
Xinyuan Real Estate Co Ltd
Nordic American Tanker Ltd
New York Mortgage Trust Inc
Ebix Inc
Losers Today's Market Change
Walter Investment Management Corp
KLA-Tencor Corp
Foot Locker Inc
Apple Inc
Anworth Mortgage Asset Corp

Disclosure: I am long WAG, XIN, NAT, NYMT, EBIX, WAC, KLAC, FL, AAPL, ANH.